EXaCT-2: An augmented and customizable oncology-focused whole exome sequencing platform
Peter Waltman, Pooja Chandra, Ken W. Eng, David C. Wilkes, Hyeon Hwan Park, Carlos Pabón-Peña, Princesca Delpe, Bhavneet Bhinder, Jyothi Manohar, Troy Kane, Evan M. Fernandez, Kathryn Gorski, Noah Greco, Manuele Simi, Jeffrey M. Tang, , Andrea Sboner
EXaCT-2 is a whole exome sequencing platform that detects various cancer-related genomic features with high accuracy and sensitivity, outperforming standard assays in detecting sub-clonal mutations and molecular metrics.
npj Precision Oncology · Apr 21, 2026Peer-reviewedGenetic & Genomic Medicine